Omicron Infected Patients

Nirog Health Tips

Shilajit's Benefits For Cardiovascular Fitness

Over the years, there has been a rise in the frequency of heart disease among young adults. This can be attributed to people's changing lifestyles and exposure to too much stress. It is crucial to take note of every item that supports a healthy heart in order to promote one. Shilajit, a naturally occurring substance found in the Himalayan mountain ranges, has been used for thousands of years in traditional Ayurvedic medicine to treat a variety of illnesses. It is renowned for its exceptional healing properties, which include antioxidant, anti-inflammatory, and anxiolytic. One of the most significant benefits of Shilajit is its positive impact on heart health. Heart conditions are common and can have serious health repercussions. Taking precautionary measures through the use of Ayurvedic ingredients can be one of the most effective ways to ensure a healthy heart. Here are some of the ways how Shilajit aids in the process: Improves Heart Health Studies suggest that Shilajit is one of the core ayurvedic ingredients in improving the health of the heart. It does so by providing strength and energy to the heart to maintain proper blood flow in all parts of the body. Ayurvedic doctors suggest Shilajit as an essential supplement to treat heart diseases as it has health-enduring properties. Since Shilajit contains fulvic acid, iron, and antioxidants like glutathione, the level of glutathione in the body is increased, which creates a line of defense against heart disease. Lowers Blood Pressure High blood pressure is a significant risk factor for heart disease. Normal blood pressure is imperative for a healthy life, and Shilajit has been found to lower blood pressure in many cases. The Ayurvedic ingredient can be used as a medium to keep blood pressure under control. This piece of Himalayan rock has worked miracles for mankind, restoring bodily cells that have been impoverished and deprived for a long time so they can operate normally once again. Shilajit blood pressure medication is also beneficial for people with heart and blood pressure issues. Shilajit provides the trace minerals that the body requires for healthy blood pressure regulation and regular bodily functions. Each of these factors makes taking the blood pressure medicine Shilajit particularly useful. Lowers Cholesterol A small study done in 2003 suggested significant improvements in cholesterol levels when around thirty people who were aged 16 to 30 years were given Shilajit. The participants were divided into two groups; the first group took 2 grams of shilajit every day for about 45 days. The cholesterol levels and triglycerides were found to be low in the Shilajit group as compared to those who did not consume Shilajit. Lowers Blood Fat Another critical compound in Shilajit is a prominent quantity of humic acid, which can significantly lower blood fats. If the concentration of fats in the body is low, there will be no fat deposits in the blood vessels, which eliminates the blockage of heart vessels. This reduces the risk of hemorrhage and stroke, which are leading causes of death in many patients. Shilajit is a natural ingredient with many health benefits for the body, especially the heart, as stated in all the aforementioned points. It is a crucial medication for the treatment of heart diseases due to its beneficial effects on arrhythmia, cardiac injury, blood pressure, cholesterol levels, and heart health. (Dr Kriti Soni, Head of R&D, Kapiva). Read More►Stay Hydrated With Tender Coconut Water
Research

Ultrasound Can Move, Break Up Kidney Stones in Awake Patients: Study

A simple ultrasound technique can be used to move, reposition or break up kidney stones, all while the patient is awake, a new study has revealed. The technique combines the use of two ultrasound technologies to offer an option to move kidney stones out of the ureter with minimal pain and no anaesthesia, according to doctors from University of Washington School of Medicine (UW Medicine). In the procedure, the physician uses a handheld transducer placed on the skin to direct ultrasound waves towards the stone. The ultrasound can then be used to move and reposition the stones to promote their passage, a process called ultrasound propulsion, or to break up the stone, a technique called burst wave lithotripsy (BWL). Unlike shock wave lithotripsy, which is the standard procedure now in use and requires sedation, this technology doesn't hurt, said lead author Dr M Kennedy Hall, an emergency medicine doctor at UW Medicine. "It's nearly painless, and you can do it while the patient is awake, and without sedation, which is critical," Hall said. The research team hopes that, with this new technology, the procedure of moving or breaking up the stones could eventually be performed in a clinic or emergency room setting. Stones in the ureter, which leads from the kidney to the bladder, can cause severe pain and are a common reason for emergency department visits. Most patients with ureteral stones are advised to wait to see if the stone will pass on its own. However, this observation period can last for weeks, with nearly one-fourth of patients eventually requiring surgery, Hall noted. Twenty-nine patients participated in the new study. Sixteen were treated with propulsion alone and 13 with propulsion and burst wave lithotripsy. In 19 patients, the stones moved. In two cases, the stones moved out of the ureter and into the bladder. Burst wave lithotripsy fragmented the stones in seven of the cases. At a two-week follow up, 18 of 21 patients (86 per cent) whose stones were located lower in the ureter, closer to the bladder, had passed their stones. In this group, the average time to stone passage was about four days, the study noted. One of these patients felt "immediate relief" when the stone was dislodged from the ureter, the study stated. Read More► Experts Make A Case for Continued Mask Use
Yoga and Fitness

Restore Your Heart With Meditation

The ancient practice of meditation can do more than just relax the mind. Recent studies have revealed that meditation can positively impact heart health by reducing stress and lowering blood pressure and heart rate. Mindfulness and meditation can benefit overall health, including heart health. The age-old practice uses quiet contemplation, breathing and sustained focus to help let go of stress and feel more calm and peaceful. It can be thought of as a mini-vacation from stress in life. Psychological stress increases the activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. This causes a release of harmful hormones cortisol, adrenaline and noradrenaline. These harmful hormones fasten the heart rate, increase cardiac output and narrow the arteries. As meditation induces deep relaxation in the mind and body, the stress subsides, and stability is restored. How to Make Meditation a Habit? Once people understand the basics of the practice, the next challenge is making it a habit. Like every other lifestyle change, it takes time to incorporate meditation into everyday life and build it into a routine. Here are some tips: Set a daily alarm on the phone or block out time on a digital calendar Try an app that reminds it's time to meditate and then record the length of the session Start by practising a few minutes every day and increase the time in small amounts until the goal is reached Meditation to Connect with the Heart's Energy Here are some simple steps to connect with the heart's Energy: Sit in a comfortable position and close your eyes. Let go of any thoughts and the world outside. Focus the attention on the spiritual heart centre (the middle of the chest) and be aware of the heart as a space. Resting the attention on the heart centre, breathe gently and sense the breath flowing into the heart. One may also visualise a coolness permeating the chest. Breathe normally and steadily. For the next few minutes, sit and listen to the heart. The heart will gradually begin to release emotions, wishes, memories, dreams and fears long stored inside. If the mind wanders, gently return to the focus on the heart. Upon completing the meditation practice, take a few moments to reflect on the practice. Why Meditation can be Useful for Heart Health? Several studies have shown that meditation can lower stress levels, reduce cortisol levels and improve heart health. Meditation can activate the "rest-and-digest" functions of the body, which counteracts the "flight-or-fight" responses. With daily meditation practice, people can lower their heart rate and blood pressure, which may reduce the risk of heart diseases. Here's a look into what different studies have to say about meditation and heart health. Researchers in 2013 at the University of Sydney found that meditation can improve HRV. It is a significant marker of mental and physical health. After spending ten intensive days learning how to meditate, meditation drastically improved the heart's responsiveness. In 2021, the American Journal of Biomedical Science and Research published a report on meditation's effect on heart rate. It revealed that with time, meditation helps the heart to beat slower and become more consistent. This indicates that meditation may be effective in preventing heart diseases. The International Journal of Exercise Science published a study in 2017 on the effect of meditation on stressed college students. Throughout the 6-week-meditation programme, blood pressure and pulse decreased significantly. It takes time to learn meditation and gain confidence, as with any new endeavour. The important thing is to practice every day, even if only for a few minutes. Meditation, no matter how brief, is always preferable to doing nothing. A schedule can also be used to establish a routine. In addition, every day, one should try to practice meditation. Daily practice can have enormous benefits not only for the heart, but also for the mind, body, and soul. (Dr. Deepak Mittal, Founder, Divine Soul Yoga) Read More► 7 Indoor Exercises to Keep You Fit During Monsoon
CoronaVirus News

ओमिक्रॉन की गंभीरता का जोखिम दोगुना कर सकता है हाई बीपी: शोध

न्यूयॉर्क: उच्च रक्तचाप रहने से कोविड के टीकों की बूस्टर खुराक लेने के बावजूद ओमिक्रॉन-वेरिएंट के संक्रमण के कारण अस्पताल में भर्ती होने का जोखिम दोगुना से अधिक हो जाता है। एक नए शोध में यह निष्कर्ष निकाला गया है। हाइपरटेंशन जर्नल में प्रकाशित शोध निष्कर्ष के मुताबिक, हाई बीपी वाले व्यक्तियों को गंभीर कोविड संक्रमण के बाद अस्पताल में भर्ती कराने की जरूरत 2.6 गुना अधिक रहती है, भले ही उन्हें पहले से कोई और गंभीर बीमारी न हो। सेंटर्स स्मिड्ट हार्ट इंस्टीट्यूट में कार्डियोलॉजी के सहायक प्रोफेसर लीड लेखक जोसेफ ई. एबिंगर ने कहा, "ब्रेकथ्रू ओमिक्रॉन संक्रमण गंभीर रूप से अस्पताल में भर्ती होने का कारण बन सकता है, यह किसी भी उम्र के वयस्क को हो सकता है, खासकर अगर किसी व्यक्ति को उच्च रक्तचाप है, भले ही उसे कोई अन्य बड़ी पुरानी बीमारी न हो। शोधकर्ताओं ने 912 वयस्कों का पूर्वव्यापी अध्ययन किया, जिन्हें एमआरएनए कोविड वैक्सीन (या तो फाइजर-बायोएनटेक या मॉडर्न) की कम से कम तीन खुराक मिली थी और दिसंबर 2021 और अप्रैल 2022 के बीच ओमिक्रॉन के मामलों में उछाल के दौरान कोविड-19 का इलाज किया गया था। विश्लेषण में पाया गया कि जिन 912 वयस्कों को एमआरएनए कोविड वैक्सीन की तीन खुराक मिली, उनमें से लगभग 16 प्रतिशत को अस्पताल में भर्ती होने की जरूरत थी। अस्पताल में भर्ती 145 मरीजों में से 125 (86.2 फीसदी) को हाई बीपी था। एबिंगर ने कहा, "हमें जागरूकता और समझ बढ़ाने की जरूरत है कि एक टीके की तीन खुराक प्राप्त करने से सभी में गंभीर कोविड-19 को रोका नहीं जा सकता, खासकर उच्च रक्तचाप वाले लोगों में। हमें कोविड-19 और उच्च रक्तचाप के संबंध को समझने के लिए और अधिक शोध करने की जरूरत है।" शोधकर्ताओं ने कहा कि आगे के अध्ययन में इस बात पर जोर दिया गया है कि गंभीर कोविड संक्रमण के जोखिम को कैसे कम किया जाए। (एजेंसी) यह भी पढ़े► कोविड के लक्षणों में सिरदर्द सबसे आम : अध्ययन
Health News

New Gene Therapy May Reduce Bleeding Risk for Haemophilia Patients

London: A team of researchers, led by those of Indian-origin, has in a breakthrough developed a single gene therapy injection that could dramatically reduce the bleeding risk faced by people with haemophilia B. Haemophilia B is a rare and inherited genetic bleeding disorder caused by low levels of the factor IX (FIX) protein, needed for forming blood clots that help prevent or stop bleeding. The gene responsible for making FIX protein is located on the X chromosome, so the severe form of haemophilia B is much more common in men. Currently, patients with haemophilia B need to inject themselves regularly usually weekly with recombinant FIX, that is, regular replacement therapy to prevent excessive bleeding. Despite advances in treatment, patients may continue to see debilitating joint damage. But the new type of adeno-associated virus (AAV) gene therapy candidate called FLT180a, developed by researchers from University College London treats severe and moderately severe cases of the condition. The study, published in the New England Journal of Medicine, showed that one-time treatment with FLT180a led to sustained production of FIX protein from the liver in nine of 10 patients across four different dose levels, removing the need for regular replacement therapy. "Removing the need for haemophilia patients to regularly inject themselves with the missing protein is an important step in improving their quality of life," said lead author Professor Pratima Chowdary, Royal Free Hospital at UCL Cancer Institute. AAV gene therapy works by using a packaging from the proteins found in the outer coat of the virus, to deliver a functional copy of a gene directly to patient tissues to compensate for one that is not working properly. Newly synthesised proteins are released into the blood and a one-time infusion can achieve long-lasting effects. Patients needed to take immunosuppressive drugs over several weeks to several months to prevent their immune systems from rejecting the therapy. While the treatment was generally well tolerated, all patients experienced some form of adverse events, with an abnormal blood clot in one who received the highest FLT180a dose and had the highest levels of FIX protein. In nine out of the 10 patients, the treatment led to a sustained increase in FIX protein production, which led to a decrease in excessive bleeding. They also no longer required weekly injections of FIX protein. After 26 weeks, five patients had normal levels of FIX protein, three had low but increased levels, and one patient treated at the highest dose had an abnormally high level. (Agency) Read More► Impact of Brain Tumour on Quality of Life
NirogStreet News

हीमोफिलिया के मरीजों की जीन

लंदन: भारतीय मूल के शोधकर्ताओं के एक दल ने एक जीन थेरेपी इंजेक्शन बनाने में सफलता हासिल की है, जो हीमोफीलिया बी से पीड़ित लोगों में होने वाले रक्तस्राव के जोखिम को कम कर सकता है। हीमोफिलिया बी एक दुर्लभ और विरासत में मिला आनुवंशिक रक्तस्राव विकार है जो कारक आइएक्स (एफआइएक्स) प्रोटीन के निम्न स्तर के कारण होता है, जो रक्त के थक्के बनाने के लिए आवश्यक होता है और रक्तस्राव को रोकने में मदद करेगा। एफआइएक्स प्रोटीन बनाने के लिए जिम्मेदार जीन एक्स गुणसूत्र पर स्थित होता है, इसलिए हीमोफिलिया बी का गंभीर रूप पुरुषों में अधिक आम है। इस समय हीमोफिलिया बी के रोगियों को नियमित रूप से खुद को इंजेक्शन लगाने की आवश्यकता होती है। पहले और दूसरे चरण में क्लीनिकल ट्रायल होता है, जिसे बी-अमेज कहते हैं। लेकिन यूनिवर्सिटी कॉलेज लंदन के शोधकर्ताओं द्वारा विकसित नए प्रकार के एडेनो-जुड़े वायरस (एएवी) जीन थेरेपी को एफएलटी 180 ए कहा गया है, जो स्थिति के गंभीर और मध्यम गंभीर मामलों का इलाज करेगा। न्यू इंग्लैंड जर्नल ऑफ मेडिसिन में प्रकाशित अध्ययन से पता चला है कि एफएलटी180ए के साथ एक बार के उपचार से दस में से नौ रोगियों में जिगर से एफआइएक्स प्रोटीन का निरंतर उत्पादन हुआ। दवाई की चार अलग-अलग डोज से नियमित थेरेपी की जरूरत समाप्त हो गई। यूसीएल कैंसर इंस्टीट्यूट में रॉयल फ्री हॉस्पिटल की प्रमुख लेखिका प्रोफेसर प्रतिमा चौधरी ने कहा, "हीमोफिलिया के रोगियों को नियमित रूप से खोए हुए प्रोटीन के साथ खुद को इंजेक्ट करने की आवश्यकता को दूर करना उनके जीवन की गुणवत्ता में सुधार करने के लिए एक महत्वपूर्ण कदम है।" एएवी जीन थेरेपी वायरस के बाहरी कोट में पाए जाने वाले प्रोटीन से पैकेजिंग का उपयोग करके काम करती है, ताकि एक जीन की कार्यात्मक प्रति सीधे रोगी के ऊतकों तक पहुंचाई जा सके। नव संश्लेषित प्रोटीन रक्त में छोड़े जाते हैं और इससे लंबे समय तक चलने वाले प्रभाव प्राप्त कर सकते हैं। मरीजों को अपनी प्रतिरक्षा प्रणाली को चिकित्सा को अस्वीकार करने से रोकने के लिए कई हफ्तों से लेकर कई महीनों तक इम्यूनोसप्रेसिव ड्रग्स लेने की जरूरत होती है। सभी रोगियों ने प्रतिकूल घटनाओं के किसी न किसी रूप का अनुभव किया, जिसमें उच्चतम एफएलटी180ए खुराक प्राप्त करने वाले और एफआइएक्स प्रोटीन का उच्चतम स्तर प्राप्त करने वाले में असामान्य रक्त का थक्का था। दस में से नौ रोगियों में, उपचार से एफआइएक्स प्रोटीन उत्पादन में निरंतर वृद्धि हुई, जिससे अत्यधिक रक्तस्राव में कमी आई। उन्हें अब एफआइएक्स प्रोटीन के साप्ताहिक इंजेक्शन की भी जरूरत नहीं है। वहीं, 26 सप्ताह के बाद पांच रोगियों में एफआइएक्स प्रोटीन का सामान्य स्तर था, तीन में निम्न लेकिन बढ़े हुए स्तर थे, और उच्चतम खुराक पर इलाज करने वाले एक रोगी का स्तर असामान्य रूप से उच्च था। यह भी पढ़े► डब्ल्यूएचओ ने मंकीपॉक्स को ग्लोबल इमर्जेसी घोषित किया